Stock Price Movement and Market Context
On 01 Oct 2026, Deep Health AI India Ltd’s stock price touched Rs.1.61, the lowest level recorded in the past year. This decline follows a two-day consecutive fall, during which the stock lost 4.73% in returns. The share price currently trades below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling sustained downward momentum.
In comparison, the broader Sensex index also experienced a decline on the same day, falling by 480.68 points or 1.06% to close at 71,712.21. The Sensex is nearing its own 52-week low, just 0.23% above the level of 71,545.81, and has been on a three-week losing streak with a cumulative loss of 4.1%. The index’s technical indicators remain bearish, trading below its 50-day moving average, which itself is positioned below the 200-day moving average.
Financial Performance and Fundamental Analysis
Deep Health AI India Ltd operates within the Gems, Jewellery and Watches sector and is classified as a micro-cap company. Its financial metrics reveal a challenging environment. The company reported a net loss after tax (PAT) of Rs. -2.15 crores in the quarter ending June 2026, representing a sharp deterioration of 3683.3% compared to prior periods. Earnings before depreciation, interest and taxes (PBDIT) also declined to Rs. -2.06 crores, while profit before tax less other income (PBT less OI) stood at Rs. -2.32 crores, both marking the lowest levels recorded.
Over the last five years, the company’s net sales have grown at a modest compound annual growth rate of 7.19%, indicating limited expansion in revenue streams. The ability to service debt remains weak, with an average EBIT to interest coverage ratio of just 0.29, underscoring financial strain. These factors contribute to the company’s current Mojo Grade of Strong Sell, a downgrade from its previous Sell rating as of 12 Dec 2025, reflecting deteriorating fundamentals.
Relative Performance and Valuation Metrics
Deep Health AI India Ltd’s stock has underperformed significantly over the past year, delivering a negative return of 63.89%, compared with the Sensex’s decline of 11.46% over the same period. The stock has also lagged behind the BSE500 index across multiple time frames, including the last three years, one year, and three months.
Despite the weak price performance, the company exhibits a return on equity (ROE) of 13.4%, which is considered fair relative to its valuation. The stock trades at a price-to-book value of 0.5, indicating it is priced at a discount compared to its peers’ historical averages. Additionally, the company offers a relatively high dividend yield of 6.06% at the current price level, which is notable given the subdued share price.
Technical Indicators and Market Sentiment
Technical analysis presents a mixed picture. On a weekly basis, the Moving Average Convergence Divergence (MACD) indicator is mildly bullish, while the monthly MACD remains bearish. The Relative Strength Index (RSI) is bullish on the weekly chart but shows no clear signal monthly. Bollinger Bands and the Know Sure Thing (KST) indicator are bearish on both weekly and monthly timeframes. The Dow Theory assessment is mildly bearish across weekly and monthly periods, and daily moving averages confirm a bearish trend. These signals collectively suggest persistent downward pressure on the stock price.
Shareholding Pattern and Market Capitalisation
The majority of Deep Health AI India Ltd’s shares are held by non-institutional investors. The company’s market capitalisation is classified as micro-cap, which often entails higher volatility and sensitivity to market fluctuations. This shareholder composition may influence trading dynamics and liquidity considerations.
Summary of Key Metrics
To summarise, Deep Health AI India Ltd’s stock has reached a 52-week low of Rs.1.61 amid a challenging market environment and company-specific financial difficulties. The stock’s recent performance has been weaker than its sector and benchmark indices, with fundamental indicators pointing to limited growth and financial stress. Technical indicators largely support a bearish outlook, while valuation metrics suggest the stock is trading at a discount relative to peers. The company’s high dividend yield stands out as a notable feature in the current pricing context.
